Spyre Therapeutics SYRE
NASDAQ SYRE
$89.03 +4.31 (+5.09%)
At close: Sep 30, 2026 · 4:00 PM EDT

Spyre Therapeutics (SYRE) Operating Expenses (2015 - 2026)

Updated

Spyre Therapeutics (SYRE) recorded Operating Expenses of $41.64 million in Q2 2026, down 0.7% from $41.94 million a year earlier and down 8.8% from the prior quarter.

Analysis

Spyre Therapeutics (SYRE) Operating Expenses (2015 - 2026) Analysis & Trends

On a TTM basis, Spyre Therapeutics' Operating Expenses came in at $201.34 million as of Jun 30, 2026, down 5.1% year-over-year; for FY2025, it was $209.56 million, up 0.5% from FY2024.

  • Annual Operating Expenses has a five-year compound annual growth rate of 20.8% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $208.57 million in FY2024 (-14.2%), $243.19 million in FY2023 (+179.2%), $87.11 million in FY2022 (+3.2%) and $84.39 million in FY2021 (+3.6%).
  • The Q2 2026 figure is the lowest quarterly Operating Expenses since Q3 2023.
  • On a year-over-year basis, Operating Expenses has declined for three consecutive quarters, with growth averaging 27.9% over the last eight quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 593.9% in Q2 2023, against a decline of 72.4% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $45.64 million (Q1 2026), $57.17 million (Q4 2025) and $56.89 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Spyre Therapeutics 7.84 Bn 7.84 Bn - 41.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.64 Mn
Mar 31, 2026 45.64 Mn
Dec 31, 2025 57.17 Mn
Sep 30, 2025 56.89 Mn
Jun 30, 2025 41.94 Mn
Mar 31, 2025 53.57 Mn
Dec 31, 2024 61.25 Mn
Sep 30, 2024 55.39 Mn
Jun 30, 2024 44.15 Mn
Mar 31, 2024 47.77 Mn
Dec 31, 2023 45.91 Mn
Sep 30, 2023 18.34 Mn
Jun 30, 2023 159.93 Mn
Mar 31, 2023 19.00 Mn
Dec 31, 2022 19.33 Mn
Sep 30, 2022 18.93 Mn
Jun 30, 2022 23.05 Mn
Mar 31, 2022 25.80 Mn
Dec 31, 2021 24.09 Mn
Sep 30, 2021 21.69 Mn
API Access

Spyre Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=SYRE&period=max&api_key=YOUR_API_KEY